GATA6 and neoplasm: GATA6-knockout cells were generated (Supplemental Figure 10B) and implanted into NSG mice, who were then treated with a dose of ETC-159 that reproducibly produces approximately 75% tumor growth inhibition in HPAF-II cells (Figure 4B and ref. 18).